The Cooper Companies, Inc. · NASDAQ:COO

The Cooper Companies — Cooper Companies — Merger or Acquisition (November 2021)

7 slides from The Cooper Companies's merger presentation, Nov 10, 2021

  1. Slide 1: CooperCompanies to Acquire Generate Life Sciences

    CooperCompanies to Acquire Generate Life Sciences® November 10, 2021 Exhibit 99.2

  2. Slide 2: Cautionary Statements

    Cautionary Statements Forward-Looking Statements This presentation contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Statements relating to guidance, plans, prospects, goals, strategies, future actions, events or performance and other statement

  3. Slide 3: Cooper to Acquire Generate Life Sciences

    New fits Trade-up Geographic expansion Torics Multifocals Pricing Cooper to Acquire Generate Life Sciences Generate Life Sciences (“Generate”) Leading life sciences company providing fertility and newborn stem cell services Leading provider of donor egg and sperm for fertility treatments & fertility

  4. Slide 4: Expands CSI Fertility and Labor & Delivery

    Expands CSI Fertility Adds frozen egg & sperm donation and fertility cryopreservation services, while enabling new strategic growth opportunities Adds leading positions and a premium reputation Leverages CSI’s strong fertility position - expanding existing relationships, leveraging sales force, and

  5. Slide 5: Fertility Donor/Cryopreservation

    Fertility Donor/Cryopreservation Egg: provides frozen donor eggs for use in fertility procedures Leader in US frozen donor egg market Largest catalog of donors in the US with a strong network of clinics for collection Sperm: provides frozen donor sperm for use in fertility procedures Largest and mos

  6. Slide 6: Stem Cell Storage

    Stem Cell Storage A leader in newborn stem cell collection and storage in the US, Canada, Australia Cord blood – collected from the umbilical cord, contains Hematopoietic Stem Cells (HSCs) used primarily for blood disorders Cord tissue – tissue from the umbilical cord, contains Mesenchymal Stem Cell

  7. Slide 7: CooperCompanies

    CooperCompanies Operating in two strong markets Revenue growth exceeding our markets Investing in the infrastructure of the business and new products Positioned to achieve long-term objectives Track record of success

Cooper Companies — Merger or Acquisition (November 2021) on 6ix